Overview
United States v. Harris, 961 F. Supp. 1127 (S.D. Ohio 1997), was a landmark case that exposed significant gaps in federal laws governing dangerous biological agents and directly influenced the passage of the Antiterrorism and Effective Death Penalty Act of 1996.
Case Facts
In May 1995, Larry Wayne Harris ordered samples of bacteria causing bubonic plague from the American Type Culture Collection (ATCC) in Maryland. He misrepresented himself to ATCC by claiming he had an Environmental Protection Agency certification number and a small animals laboratory when neither was true.
Legal Outcome
The court convicted Harris of fraudulently misrepresenting himself to obtain the bacteria. However, if Harris had not used fraudulent misrepresentation, the court would not have convicted him of anything because gaps in existing laws enabled anyone to obtain dangerous pathogens without legitimate purpose.
Impact on Legislation
Senator Orrin G. Hatch introduced the Biological Agents Enhanced Penalties and Control Act (later incorporated into the 1996 Act) specifically in response to this case, noting that Mr. Harris's purchase demonstrated how easily a determined individual could acquire biological weapons materials. Attorney General Janet Reno later cited this incident as evidence that federal agencies lacked adequate resources and personnel to respond effectively to bioterrorism.
Broader Implications
The case highlighted three key problems: (1) existing laws did not criminalize possession of dangerous pathogens without intent to use them as weapons, (2) regulations only covered transferors/shippers rather than all possessors, and (3) the CDC's classification system failed to account for new strains or provide adequate definitions. These gaps were later addressed through amendments to 18 U.S.C. §§ 175-178.